Torys LLP acted for Entos Pharmaceuticals on the deal. Entos Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. entered into an agreement that will see Entos apply its Fusogenix nucleic…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
